Similar Posts
Global Payments Stock: Interesting Even With A Mild Recession (NYSE:GPN)
This article was written by Follow “Fundamental Options” would be the title of my investing style, because I combine fundamental analysis with the power of options. I use Fundamental Analysis to quantitatively and qualitatively assess individual stocks and ETFs, and I pursue various strategies: Income oriented, especially BDCs, but also Utilities; Growth At A Reasonable…
USDCAD and USDCNH: USDCAD is treading above 1.37800 level
On Monday, the USDCAD rose to 1.37819 levels, followed by a pullback at 1.37500. Pair USDCNH continues this week with previous bullish consolidation. USDCAD chart analysis On Monday, the USDCAD rose to 1.37819 levels, followed by a pullback at 1.37500. This morning’s Asian trading session brought stability and initiated a recovery to the 1.37750 level….
Home Run Number 63
Today, I’m happy to announce DivGro’s 63rd Home Run! I call the stocks in my DivGro portfolio Home Runs after they double my original investment on a total-return basis. As a dividend growth investor, I invest in high-quality dividend growth stocks with long histories of increasing annual dividend payouts. There’s rarely a reason to sell high-quality dividend-growth stocks if…
TickStack Grid Systems – User Guide
TickStack Grid Systems – User Guide This guide covers the common input parameters shared across all TickStack grid-based Expert Advisors, including Gold Matrix, ChronomaX, Aussie Victor, Neural Nexus, and other grid systems. While each EA features unique entry models and grid management algorithms tailored to specific market conditions and instruments, they all share the same…
These 4 TSX Stocks Pay Monthly Dividends and Are Less Than $20/Share
Image source: Getty Images The Bank of Canada has slashed interest rates twice this year, and investors are hoping for one more rate cut. Amid falling interest rates, investing in monthly-paying dividend stocks would be an excellent strategy to earn a stable passive income. Meanwhile, the following four stocks pay dividends monthly and are trading…
Aurobindo Pharma Q3 net profit drops 10% to Rs 846 crore
Aurobindo Pharma on Thursday reported a 10% year-on-year (YoY) decline in net profit to Rs 846 crore in the third quarter ended December 2023, dragged by US sales. despite strong growth momentum in Europe, growth markets and antiretrovirals segment. The company posted net profit of Rs 940 crore in the corresponding quarter of previous year….
